Application based on results from TRANSCEND CLL 004, the first pivotal multicenter trial to show clinical benefit with a CAR T cell therapy in heavil...
Under the terms of the option agreement, AbbVie has the option to acquire a co-exclusive license to develop, manufacture, and commercialize reproxalap in t...
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as ea...
Quantum Leap Healthcare Collaborative (QLHC) announces the enrollment launch for the Re-Evaluating Conditions for Active Surveillance Suitability as Treatm...
The initiative was introduced to translate the traceability, certifications, as well as the environmental and social impact of the company’s ingredie...
In the Phase 1b study, favorable trends were reported for the high-dose groups on multiple measures of cognition and function. First study of a tau targ...
LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned fl...
Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...
Advicenne expanded partnership validates Avanzanite’s execution capabilities and unwavering commitment to the smallest countries in Europe. Avanzani...
Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, has today announced the acquisition of Berkshire Ste...
Combination arms to treat patients in first-line setting, providing valuable insights on future development potential for this patient population Phase ...
Hansa Biopharma, "Hansa", a pioneer in enzyme technology for rare immunological conditions, announced high-level results from NICE-01, the first-in-h...
Ad hoc announcement pursuant to Art. 53 LR Novartis executes separation of the Sandoz business to create an independent company by way of a 100% S...
BIOVECTRA and Acuitas Therapeutics, Inc. announced that they have entered into a technology transfer service agreement under which BIOVECTRA will acc...
© 2024 Biopharma Boardroom. All Rights Reserved.
